Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.33 |
| ▸ | USP9X | Q93008 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7015564 | 0.85 | MEN1 (0.60) | MEN1KMT2AKDM4ELMNAMGAM | |
| SCHEMBL7010073 | 0.82 | MEN1 (0.52) | MEN1KMT2AKDM4ELMNAMAPK8 | |
| SCHEMBL27359670 | 0.80 | LMNA (0.41) | MEN1KMT2AKDM4ELMNAMCHR1 | |
| SCHEMBL7013166 | 0.74 | MCHR1 (0.46) | MEN1KMT2ALMNAMCHR1DPP4 | |
| Methoxymethane SCHEMBL27938732 | 0.73 | KDM4E (0.87) | MEN1KMT2AKDM4ELMNAHTT | |
| SCHEMBL30505600 | 0.73 | KDM4E (1.00) | MEN1KMT2AKDM4ELMNADPP4 | |
| SCHEMBL125654 | 0.73 | KDM4E (1.00) | MEN1KMT2AKDM4ELMNADPP4 | |
| SCHEMBL30381290 | 0.73 | KDM4E (1.00) | MEN1KMT2AKDM4ELMNADPP4 | |
| SCHEMBL7015349 | 0.72 | MEN1 (0.55) | MEN1KMT2AKDM4ELMNAMAPK8 | |
| Fluoride SCHEMBL28821496 | 0.71 | KDM4E (0.96) | MEN1KMT2AKDM4ELMNADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020099072-A1 | [1,8] naphthyridine derivatives having antiviral activity | BIOCHEM PHARMA INC. | 2002-07-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099072-A1 | [1,8] naphthyridine derivatives having antiviral activity | HAVCR2, MAVS, NTPCR | MEN1 4721/4885KMT2A 4352/4885KDM4E 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.